[Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the Clinical Use of Cytoprotectives].
Büntzel
J
J
Klinik für HNO-Krankheiten, Zentralklinikum Suhl, Suhl.
Bokemeyer
C
C
Wagner
W
W
D004999:Amifostine / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D019610:Cytoprotection / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D015080:Mesna / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*; D017410:Practice Guidelines as Topic; D011837:Radiation-Protective Agents / Q000008:administration & dosage
D000970:Antineoplastic Agents; D011837:Radiation-Protective Agents; D004999:Amifostine; D015080:Mesna